YSN.DEYSN.DEXETRA
Loading
Year-over-year research & development expense growth
Percentile
P81
Within normal range
vs 2Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q2 2025 | 150.28% |
| Q4 2024 | -18.59% |
| Q2 2024 | 30.81% |
| Q4 2023 | 26.14% |
| Q2 2023 | -15.02% |
| Q4 2022 | 20.51% |
| Q2 2022 | -10.64% |
| Q4 2021 | 99.16% |
| Q2 2021 | 245.54% |
| Q4 2020 | -33.66% |
| Q2 2020 | 1352.71% |
| Q4 2019 | -81.52% |
| Q2 2019 | -37.54% |
| Q4 2018 | 79.20% |
| Q2 2018 | -82.63% |
| Q4 2017 | 16772.35% |
| Q2 2017 | 91.38% |
| Q4 2016 | -85.32% |
| Q2 2016 | 432.47% |
| Q4 2015 | 142.03% |
| Q2 2015 | -203.80% |
| Q4 2014 | -72.21% |
| Q2 2014 | 653.93% |
| Q4 2013 | 833.59% |
| Q2 2013 | 0.00% |
| Q4 2012 | 0.00% |
| Q2 2012 | 0.00% |
| Q4 2011 | 0.00% |
| Q2 2011 | 0.00% |
| Q4 2010 | 0.00% |
| Q2 2010 | 0.00% |
| Q4 2009 | 0.00% |
| Q2 2009 | 0.00% |